Cargando…
Cardioprotective effect of carvedilol: inhibition of apoptosis in H9c2 cardiomyocytes via the TLR4/NF-κB pathway following ischemia/reperfusion injury
Carvedilol is a non-selective β-blocker used in the treatment of cardiovascular disease, including myocardial ischemia. The aim of the present study was to investigate the molecular mechanisms underlying the effects of carvedilol on simulated ischemia/reperfusion (SI/R)-induced cardiomyocyte apoptos...
Autores principales: | ZHAO, YONG, XU, YAN, ZHANG, JIANHUA, JI, TINGTING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151635/ https://www.ncbi.nlm.nih.gov/pubmed/25187802 http://dx.doi.org/10.3892/etm.2014.1863 |
Ejemplares similares
-
Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol
por: Skrzypiec-Spring, Monika, et al.
Publicado: (2021) -
Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion Injury
por: Chen, Yi-Wen, et al.
Publicado: (2013) -
Effects of Carvedilol on liver ischemia-reperfusion injury in rats
por: Tolga Kafadar, Mehmet, et al.
Publicado: (2022) -
Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia/reperfusion-induced injury in H9c2 cardiomyocytes
por: Hu, Shuoqiang, et al.
Publicado: (2017) -
The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury
por: Hu, Fan, et al.
Publicado: (2012)